Clinical and pathological characterization of epstein-barr virus-associated gastric carcinomas in portugal

AIM To determine the prevalence of epstein-barr virus(eb V)-associated gastric carcinomas in the North Region of Portugal and to study its clinicopathological characteristics. METHODS We have performed a retrospective study including a total of 179 consecutive patients with gastric cancer(GC) submit...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 23; no. 40; pp. 7292 - 7302
Main Authors Ribeiro, Joana, Oliveira, Andreia, Malta, Mariana, Oliveira, Claudia, Silva, Fernanda, Galaghar, Ana, Afonso, Luís Pedro, Neves, Maria Cassiano, Medeiros, Rui, Pimentel-Nunes, Pedro, Sousa, Hugo
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIM To determine the prevalence of epstein-barr virus(eb V)-associated gastric carcinomas in the North Region of Portugal and to study its clinicopathological characteristics. METHODS We have performed a retrospective study including a total of 179 consecutive patients with gastric cancer(GC) submitted to gastrectomy during 2011 at the Portuguese Oncology Institute of Porto. Clinical and pathological data was collected from individual clinical records and inserted on a database with unique codification. Tumour tissues were collected from the institutional tumour bank. eb V was detected by in situ hybridization for the detection of eb V-encoded small RNAs(ebe Rs) and eb V latent proteins(LMP1 and LMP2 A) were detected by immunohistochemistry.RESULTS The analysis showed that eb V-associated gastric carcinomas(eb Va GC) represents 8.4%(15/179) of all GC cases, with a significant differential distribution among histological types(P < 0.001): 100%(3/3) of medullary carcinomas, 100%(1/1) of adenosquamous carcinoma, 8.7%(8/92) of tubular adenocarcinomas, 8.0%(2/25) of mixed carcinomas and 2%(1/51) in poorly cohesive carcinomas. The analysis revealed a higher predominance of eb Va GC in the upper third and middle(cardia, fundus and body) of the stomach(P = 0.041), a significant lower number of regional lymph nodes invasion(P = 0.025) and a tendency for better prognosis(P = 0.222). eb V latent protein expression revealed that all eb Va GC cases were LMP1-negative, nevertheless 6 cases(40%) expressed LPM2 A, which reveals that these cases show a distinct eb V-Latency profile(latency II-like).CONCLUSION eb Va GC represents 8.4% of all GC in the North Region of Portugal. The eb V-infected patients have specific clinic-pathological features that should be further explored to develop new strategies of management and treatment.
Bibliography:Joana Ribeiro;Andreia Oliveira;Mariana Malta;Claudia Oliveira;Fernanda Silva;Ana Galaghar;Luís Pedro Afonso;Maria Cassiano Neves;Rui Medeiros;Pedro Pimentel-Nunes;Hugo Sousa;Molecular Oncology and Viral Pathology Group, Portuguese Oncology Institute of Porto;Faculty of Medicine of Porto University;Department of Pathology, Portuguese Oncology Institute of Porto;Medical Oncology Department, Portuguese Oncology Institute of Porto;Instituto CUF de Oncologia;Virology Service, Portuguese Oncology Institute of Porto;Research Department-Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte);Gastroenterology Service, Portuguese Oncology Institute of Porto;CINTESIS - Center for Health Technology and Services Research (Centro de Investiga??o Médica, Faculdade de Medicina da Universidade do Porto)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Ribeiro J, Oliveira A, Malta M and Oliveira C performed the laboratory of experiments; Silva F and Galaghar A were responsible for the histological sectional selection; Galaghar A and Afonso LP revised the histological classification; Neves MC and Ribeiro J revised all clinical data; Medeiros R and Pimentel-Nunes P supervised the research and clinical data, respectively; Ribeiro J and Sousa H designed the study and performed the data analysis; Sousa H coordinated the study; Ribeiro J and Sousa H prepared the manuscript; all authors revised and collaborated in the manuscript writing and final preparation.
Correspondence to: Hugo Sousa, MD, PhD, Grupo de Oncologia Molecular e Patologia Viral, Laboratórios 4º Piso, Instituto Português de Oncologia do Porto FG EPE, Rua Dr. António Bernardino Almeida, 4200-072 Porto, Portugal. hugo.sousa@ipoporto.min-saude.pt
Telephone: +351-225-084000-5410 Fax: +351-225-084001
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v23.i40.7292